Center for drug evaluation and research - new drugs regulatory program modernization, prepare, design, and implement
Ended Awarded Last action
- Contract number
- HHSF22318001
- Awardee
-
Mckinsey & Company, Inc. Washington D.c. UEI N6JZARL64EW5 Part of Mckinsey & Company, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,981,599
Award facts
- Contract value 92% obligated
-
- $3,981,599.26 Current, with exercised options
- $4,328,544.04 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$10,404 | |
| Additional Work (new agreement, FAR part 6 applies) | $1,436,312 | |
| Additional Work (new agreement, FAR part 6 applies) | $233,423 | |
| Original award | $2,322,268 |
About this award
The Department of Health and Human Services Food and Drug Administration awarded a $4,328,544.04 firm fixed-price contract to McKinsey & Company, Inc. Washington D.C. to support the Center for Drug Evaluation and Research's New Drugs Regulatory Program Modernization initiative. The contract, which falls under the General Services Administration's Professional Services Schedule, requires McKinsey to prepare, design, and implement solutions to modernize the FDA's new drug regulatory processes. This award is not set aside and does not identify any major subcontractors. As a leading management consulting firm, McKinsey has extensive experience supporting federal agencies like the Department of Veterans Affairs and Department of Defense on initiatives spanning strategy, organizational transformation, and program implementation.
Quick answers
Who was awarded contract HHSF22318001?
HHSF22318001 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on December 5, 2017.
How much is contract HHSF22318001 worth?
The government has obligated $3,981,599 on HHSF22318001. Its potential value, with all options, is $4,328,544.
Is contract HHSF22318001 an order under another contract?
Yes. HHSF22318001 is a BPA call under GS10F0118S-HHSF223201700022B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract HHSF22318001 competed?
The extent of competition for HHSF22318001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award